dacarbazine,doxorubicin,brentuximab vedotin,vinblastine,bleomycin,vincristine
seagen
['lymsm']
ghsg hd21 rct of brecadd vs ebeacopp #17icml
- 1500 pts (!!!), median age 34 [18-61]
- 3-yr pfs 95% with bre
- non-inferiority of brecadd confimed
- 10 deaths bea, 11 deaths bre
new soc for an outpatient regimen in advanced chl? #lymsm 
Lymphoma doc & patient-reported outcomes researcher in #lymsm and #mmsm @CUHematology. Founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. 🏳️‍🌈